Radiation Oncology/Therapy: Page 29

ViewRay reports revenue spike for Q2
By AuntMinnie.com staff writers
Image-guided radiation therapy vendor ViewRay reported a major increase in revenues for the second quarter of 2022.
August 2, 2022
2019 09 17 16 42 0082 Viewray Astro 2019
CEUS-guided biopsy shows superiority in liver imaging
By Amerigo Allegretto
Biopsy guided by contrast-enhanced ultrasound (CEUS) is effective, safe, and more accurate than conventional ultrasound-guided biopsy when it comes to diagnosing focal liver lesions, a multicenter study published August 2 in Radiology found.
August 2, 2022
2022 08 02 21 12 0949 2022 08 02 Radiology Wu Ceus Liver Lesions 400
Navidea highlights research on melanoma, oral cancer
By AuntMinnie.com staff writers
Radiopharmaceutical developer Navidea Biopharmaceuticals is directing attention to new research from Australia on the use of its technetium-99m tilmanocept radiopharmaceutical in patients with melanoma or oral cancer.
August 1, 2022
2022 01 20 22 04 8815 Melanoma 400
Shine submits drug master file for Lu-177
By AuntMinnie.com staff writers
Medical isotope firm Shine Technologies has submitted a drug master file with the U.S. Food and Drug Administration for its non-carrier-added lutetium-177 (Lu-177) chloride radiopharmaceutical.
July 31, 2022
2018 12 11 00 02 7009 Atom Nuclear Lab 400
French university hospital picks ViewRay rad therapy system
By AuntMinnie.com staff writers
ViewRay said Centre Oscar Lambret has become the first university hospital in Lille, France, to acquire its MRIdian MRI-guided radiation therapy system.
July 28, 2022
2019 09 17 16 42 0082 Viewray Astro 2019
IceCure files for Canadian regulatory clearance for ProSense
By AuntMinnie.com staff writers
IceCure Medical has filed paperwork with Health Canada requesting clearance for market of its ProSense liquid nitrogen-based cryoablation system.
July 25, 2022
2019 02 12 23 11 2325 Canada Flag 400
Sources: Biden picks Bertagnolli as NCI director
By AuntMinnie.com staff writers
President Joe Biden has picked surgical oncologist Dr. Monica Bertagnolli as the next director of the U.S. National Cancer Institute (NCI), according to multiple sources. She will become the first woman to lead the NCI since the institute's founding in 1937.
July 24, 2022
2021 05 14 17 28 5631 Business Woman Speaker 400
ITM selects Marx as chief business officer
By AuntMinnie.com staff writers
German radiopharmaceutical developer ITM Isotope Technologies Munich has named Sebastian Marx, PhD, as its chief business officer.
July 24, 2022
2020 04 22 17 11 4900 Business Handshake Man 400
NorthStar inks Ac-225 supply deal with Clovis
By AuntMinnie.com staff writers
NorthStar Medical Radioisotopes has signed a long-term supply agreement with Clovis Oncology for NorthStar's actinium-225 (Ac-225) therapeutic radioisotope.
July 20, 2022
2018 04 24 20 24 4264 Isotope 400
Clarity completes recruitment for prostate cancer trial
By AuntMinnie.com staff writers
Australian radiopharmaceutical developer Clarity Pharmaceuticals has completed recruitment for a PET study of its theranostic agent with copper-based radioisotopes for treating patients with prostate cancer.
July 19, 2022
2021 01 16 00 14 5464 Prostate Cancer 400
ViewRay receives order from Japanese university
By AuntMinnie.com staff writers
Image-guided radiation therapy vendor ViewRay has secured an order for its MRIdian MRI-guided radiation therapy system from Saitama Medical University International Medical Center in Japan.
July 18, 2022
2019 09 17 16 42 0082 Viewray Astro 2019
FDA clears Radialis PET imager
By AuntMinnie.com staff writers
The U.S. Food and Drug Administration (FDA) has cleared Radialis' PET Imager, a small footprint, organ-targeted device.
July 17, 2022
2022 07 18 18 48 3323 2022 07 18 Radialis 400
Previous Page
Page 29 of 466
Next Page